Total trials
222
Active
13
Phase 3
82
Total enrollment
58,258
Pipeline matrix
Showing 7 of 7 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Eptinezumab | — | — | — | 16 | |||
| Amlenetug | — | — | — | — | — | 1 | |
| Lu AF28996 | — | — | — | — | 7 | ||
| Lu AG13909 | — | — | — | — | — | 2 | |
| Lu AF82422 | — | — | — | — | 3 | ||
| Lu AG22515 | — | — | — | — | — | 2 | |
| Lu AH69593 | — | — | — | — | — | 1 |
Next readouts
- 2023-11-16
- 2026-03-17
- 2026-06-05
- 2026-09-05
- 2026-09-15
- 2026-09-30
- 2026-12-01
- 2027-05-31
- 2027-07-06
- 2028-02-17
Top conditions
- Healthy34
- Major Depressive Disorder29
- Schizophrenia28
- Migraine15
- Alzheimer's Disease10
- Primary Insomnia10
- Healthy Participants9
- Parkinson Disease8
Frequently asked questions about H. Lundbeck A/S
- How many clinical trials does H. Lundbeck A/S have on ClinicalTrials.gov?
- H. Lundbeck A/S is listed as the lead sponsor on 222 clinical trials in ClinicalTrials.gov, 13 of which are currently active (recruiting, enrolling, or ongoing).
- How many of H. Lundbeck A/S's trials are in Phase 3?
- 82 of H. Lundbeck A/S's trials are in Phase 3, spread across 7 active drug programs.
- What therapeutic areas does H. Lundbeck A/S focus on?
- H. Lundbeck A/S's most-studied conditions on ClinicalTrials.gov are Healthy, Major Depressive Disorder, Schizophrenia, Migraine, Alzheimer's Disease.
- When are H. Lundbeck A/S's next clinical trial readouts?
- H. Lundbeck A/S has 10 upcoming primary-completion readouts tracked here; the soonest is “A Study of Lu AF82422 in Participants With Multiple System Atrophy”, expected around 2023-11-16.